An Analysis of NICE's `Restricted' (or `Optimized') Decisions

Author： O'Neill Phill   Devlin Nancy J.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.28, Iss.11, 2010-11, pp. : 987-993

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent decisions from NICE

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 669, 2013-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Recent NICE decisions for cancer drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 637, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

NICE decisions on treatment of ovarian cancer and ischaemic heart disease released

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 263, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

The social and cultural construction of psychiatric knowledge: an analysis of NICE guidelines on depression and ADHD

By Moncrieff Joanna   Timimi Sami  

Anthropology & Medicine, Vol. 20, Iss. 1, 2013-04 ,pp. : 59-71

Routledge Ltd

Access to resources Recommend Favorite

Better Analysis for Better Decisions: Facing Up to the Challenges

By Drummond Michael F.   Sculpher Mark J.  

PharmacoEconomics, Vol. 24, Iss. 11, 2006-01 ,pp. : 1039-1042

Adis International

Access to resources Recommend Favorite